By using the inhibitor of Cathepsin D, Pepstatin A, it was possible to inhibit the amount of cleaved AnxA1, to induce apoptosis, and to decrease the invasion and migration of triple-negative breast cancer cells. The gene discussed is ANXA1; the disease is triple-negative breast carcinoma.